Prudential Financial’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.4K | Buy |
18,255
+7,610
| +71% | +$23.5K | ﹤0.01% | 2334 |
|
|
2025
Q1 | $37.2K | Buy |
+10,645
| New | +$37.2K | ﹤0.01% | 2220 |
|
|
2024
Q3 | – | Sell |
-14,975
| Closed | -$46.3K | – | 2706 |
|
|
2024
Q2 | $46.3K | Buy |
14,975
+2,390
| +19% | +$7.39K | ﹤0.01% | 2619 |
|
|
2024
Q1 | $32.5K | Hold |
12,585
| – | – | ﹤0.01% | 2626 |
|
|
2023
Q4 | $31.5K | Buy |
12,585
+1,220
| +11% | +$3.05K | ﹤0.01% | 2591 |
|
|
2023
Q3 | $23.1K | Hold |
11,365
| – | – | ﹤0.01% | 2567 |
|
|
2023
Q2 | $26.1K | Hold |
11,365
| – | – | ﹤0.01% | 2591 |
|
|
2023
Q1 | $34.4K | Sell |
11,365
-81,900
| -88% | -$248K | ﹤0.01% | 2530 |
|
|
2022
Q4 | $217K | Buy |
93,265
+58,900
| +171% | +$137K | ﹤0.01% | 2376 |
|
|
2022
Q3 | $65K | Buy |
34,365
+125
| +0.4% | +$236 | ﹤0.01% | 2542 |
|
|
2022
Q2 | $93K | Sell |
34,240
-422,420
| -93% | -$1.15M | ﹤0.01% | 2535 |
|
|
2022
Q1 | $1.36M | Buy |
456,660
+51,300
| +13% | +$153K | ﹤0.01% | 1734 |
|
|
2021
Q4 | $1.58M | Buy |
+405,360
| New | +$1.58M | ﹤0.01% | 1649 |
|